World's Best Scientists 2026 revealed!
Angela Tincani

Angela Tincani

Award Badge
Best Female Scientists
2025
Award Badge
Immunology
Italy
2025

D-Index & Metrics

Best Female Scientists

D-Index
111
Citations
53981
World Ranking
840
National Ranking
19

Immunology

D-Index
112
Citations
56076
World Ranking
444
National Ranking
12

Medicine

D-Index
113
Citations
58179
World Ranking
4872
National Ranking
150

Research.com Recognitions

  • 2025 - Research.com Best Female Scientists Award
  • 2025 - Research.com Immunology in Italy Leader Award

Overview

Angela Tincani is affiliated with the University of Brescia in Italy and has contributed extensively to the field of Medicine, focusing specifically on Rheumatology. Their research encompasses multiple subfields including Public Health, Environmental and Occupational Health, Immunology, Surgery, and Genetics.

The research work primarily addresses topics related to Systemic Lupus Erythematosus Research, Pregnancy and Medication Impact, and broader aspects of the Reproductive System and Pregnancy. Other notable areas include Monoclonal and Polyclonal Antibodies Research, Renal Diseases and Glomerulopathies, Platelet Disorders and Treatments, and Systemic Sclerosis and Related Diseases.

Coauthorship has been a significant aspect of this scientist's publications, frequently collaborating with colleagues such as Laura Andréoli, Franco Franceschini, Cecilia Nalli, Micaela Fredi, and Marta Mosca.

Angela Tincani has published numerous papers in prominent venues. The most frequent publication venues include Annals of the Rheumatic Diseases, Lara D. Veeken, Autoimmunity Reviews, Poster presentations, and Clinical and Experimental Rheumatology.

Significant papers authored or coauthored by Angela Tincani include:

  • EULAR recommendations for the management of systemic lupus erythematosus: 2023 update (2023), Annals of the Rheumatic Diseases
  • Covid-19 and autoimmunity (2020), Autoimmunity Reviews
  • The 2023 ACR/EULAR Antiphospholipid Syndrome Classification Criteria (2023), Arthritis & Rheumatology
  • 2023 ACR/EULAR antiphospholipid syndrome classification criteria (2023), Annals of the Rheumatic Diseases
  • 2021 DORIS definition of remission in SLE: final recommendations from an international task force (2021), Lupus Science & Medicine

Best Publications

  • International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS).

    S. Miyakis;M. D. Lockshin;T. Atsumi;D. W. Branch

  • Antiphospholipid syndrome: Clinical and immunologic manifestations and patterns of disease expression in a cohort of 1,000 patients

    Ricard Cervera;Jean Charles Piette;Josep Font;Munther A. Khamashta

  • 2019 update of the EULAR recommendations for the management of systemic lupus erythematosus

    Antonis Fanouriakis;Myrto Kostopoulou;Alessia Alunno;Martin Aringer

  • EULAR recommendations for the management of antiphospholipid syndrome in adults

    Maria G Tektonidou;Laura Andreoli;Marteen Limper;Zahir Amoura

  • The EULAR Points to Consider for Use of Antirheumatic Drugs Before Pregnancy, and During Pregnancy and Lactation

    Carina Götestam Skorpen;Maria Hoeltzenbein;Angela Tincani;Rebecca Fischer-Betz

  • EULAR recommendations for the management of systemic lupus erythematosus. Report of a Task Force of the EULAR Standing Committee for International Clinical Studies Including Therapeutics

    G. Bertsias;J. P. A. Ioannidis;J. Boletis;S. Bombardieri

  • EULAR recommendations for women's health and the management of family planning, assisted reproduction, pregnancy and menopause in patients with systemic lupus erythematosus and/or antiphospholipid syndrome

    L. Andreoli;G. K. Bertsias;N. Agmon-Levin;S. Brown

  • EULAR recommendations for the management of systemic lupus erythematosus with neuropsychiatric manifestations: report of a task force of the EULAR standing committee for clinical affairs

    G K Bertsias;J P A Ioannidis;M Aringer;E Bollen

  • Morbidity and mortality in the antiphospholipid syndrome during a 10-year period: a multicentre prospective study of 1000 patients

    R. Cervera;M. A. Khamashta;Y. Shoenfeld;M. T. Camps

  • EULAR recommendations for the management of systemic lupus erythematosus: 2023 update

    Unknown

  • Rivaroxaban vs warfarin in high-risk patients with antiphospholipid syndrome.

    Vittorio Pengo;Gentian Denas;Giacomo Zoppellaro;Seena Padayattil Jose

  • Vitamin D and musculoskeletal health, cardiovascular disease, autoimmunity and cancer: Recommendations for clinical practice.

    Jean Claude Souberbielle;Jean Jacques Body;Joan M. Lappe;Mario Plebani

  • International recommendations for the assessment of autoantibodies to cellular antigens referred to as anti-nuclear antibodies

    Nancy Agmon-Levin;Nancy Agmon-Levin;Jan Damoiseaux;Cornelis Kallenberg;Ulrich Sack

  • Anti-inflammatory and immunosuppressive drugs and reproduction.

    Monika Østensen;Munther Khamashta;Michael Lockshin;Ann Parke

  • Risk of congenital complete heart block in newborns of mothers with anti-Ro/SSA antibodies detected by counterimmunoelectrophoresis: A prospective study of 100 women

    Antonio Brucato;Micol Frassi;Franco Franceschini;Rolando Cimaz

  • Covid-19 and autoimmunity.

    Michael Ehrenfeld;Angela Tincani;Laura Andreoli;Marco Cattalini

  • European League Against Rheumatism recommendations for monitoring patients with systemic lupus erythematosus in clinical practice and in observational studies

    Marta Mosca;C. Tani;M. Aringer;S. Bombardieri

  • ANTIPHOSPHOLIPID ANTIBODIES AFFECT TROPHOBLAST GONADOTROPIN SECRETION AND INVASIVENESS BY BINDING DIRECTLY AND THROUGH ADHERED β2-GLYCOPROTEIN I

    N Di Simone;P L Meroni;N Del Papa;E Raschi

  • The 2023 ACR/EULAR Antiphospholipid Syndrome Classification Criteria

    Unknown

  • 2023 ACR/EULAR antiphospholipid syndrome classification criteria

    Unknown

  • A framework for remission in SLE: consensus findings from a large international task force on definitions of remission in SLE (DORIS)

    Ronald van Vollenhoven;Alexandre Voskuyl;George Bertsias;Cynthia Aranow

  • Statins prevent endothelial cell activation induced by antiphospholipid (anti–β2-glycoprotein I) antibodies: Effect on the proadhesive and proinflammatory phenotype

    Pier L. Meroni;Elena Raschi;Cinzia Testoni;Angela Tincani

  • Euro-Phospholipid Project Group (European Forum on Antiphospholipid Antibodies). Morbidity and mortality in the antiphospholipid syndrome during a 5-year period: a multicentre prospective study of 1000 patients

    R Cervera;Ma Khamashta;Y Shoenfeld;Mt Camps

Frequent Co-Authors

Franco Franceschini
Franco Franceschini University of Brescia
Pier Luigi Meroni
Pier Luigi Meroni Istituto Auxologico Italiano
Andrea Doria
Andrea Doria University of Padua
Ilaria Cavazzana
Ilaria Cavazzana University of Brescia
Marta Mosca
Marta Mosca University of Pisa
Paolo Airò
Paolo Airò University of Brescia
Yehuda Shoenfeld
Yehuda Shoenfeld Sheba Medical Center
Guido Valesini
Guido Valesini Sapienza University of Rome
Maurizio Cutolo
Maurizio Cutolo University of Genoa
Ricard Cervera
Ricard Cervera University of Barcelona

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Pursuing a career in Immunology often aligns well with healthcare roles that require advanced clinical knowledge. For those interested in nursing, enrolling in an nurse practitioner accelerated program provides a fast-tracked pathway to gain essential skills and credentials. These programs help prepare graduates for specialized roles where immunology expertise is highly valued.

Many aspiring professionals come from non-nursing backgrounds and look for options like online accelerated nursing programs for non nurses. These programs offer a practical transition into the nursing field, facilitating a smooth entry point into immunology-related healthcare careers.

Once in nursing, advancement opportunities include certifications such as the acute care nurse practitioner certification, which prepares nurses to manage critical care patients with complex immune system disorders. This certification enhances career prospects in immunology-intensive environments.

For those beginning their nursing education, exploring the easiest absn programs to get into can be advantageous. These programs offer accessible entry points and rigorous training necessary to build a foundation for advanced immunology study and practice.

Best Scientists Citing Angela Tincani

Trending Scientists

Recently Published Articles